Medical cannabis can be a pain to access.
Still, there are people who are trying to make it easier on patients.
Joel Taylor is one of them.
“Medical cannabis needs to be much more accessible to Canadians,” he tells the oz. “We’re a scrappy little startup and we’re trying to fight the good fight. Hopefully we can provide a little bit of a disruption, a little bit of shakeup here to get people to realize that it doesn’t have to be the way that it is.”
Taylor, who’s been involved in medical cannabis for a long time, co-founded Patient Choice as a portal to provide more variety and better prices on the medical side.
“After recreational cannabis came to Canada there was an enormous vacuum in the industry, and a lot of licensed producers turned their back on medical cannabis altogether. Without medical cannabis patients, we wouldn’t have recreational today,” he says.
In some cases, clinics that are willing and able to prescribe cannabis are asking for a “ludicrous” 30% commission from LPs, he says.
“We just really struggle with the idea of a doctor reaching out to someone like GlaxoSmithKline and telling them that they’re going to need 30% of the bottom line in order to prescribe cancer medication to someone. We think that’s not something that’s sustainable anymore in socialized medicine here in Canada,” he says.
“We’re seeing medical clinics treating patients as though they’re a property or that they’re a consumable that they can vend out to licensed producers."
More choice, less cost
Patient Choice gives medical cannabis patients freedom to purchase from a range of providers, competitively priced on one platform.
The numerous supplier partnerships include TGOD, Tantalus, and GTEC. Patient Choice is adding more producers, processors, and nurseries.